Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Tralokinumab> ?p ?o }
Showing triples 1 to 57 of
57
with 100 triples per page.
- Tralokinumab abstract "Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354 and taken through pre-clinical development. As of April 2012 it is being developed by MedImmune, a member of the AstraZeneca group, where it is currently in Ph3 testing for asthma and Ph2 testing for atopic dermatitis. This makes it one of the few fully internally discovered and developed drug candidates in AstraZeneca's late stage development pipeline.".
- Tralokinumab atcPrefix "none".
- Tralokinumab casNumber "1044515-88-9".
- Tralokinumab wikiPageID "33024164".
- Tralokinumab wikiPageLength "6065".
- Tralokinumab wikiPageOutDegree "13".
- Tralokinumab wikiPageRevisionID "673257712".
- Tralokinumab wikiPageWikiLink Asthma.
- Tralokinumab wikiPageWikiLink AstraZeneca.
- Tralokinumab wikiPageWikiLink Cambridge_Antibody_Technology.
- Tralokinumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Tralokinumab wikiPageWikiLink Interleukin_13.
- Tralokinumab wikiPageWikiLink MedImmune.
- Tralokinumab wikiPageWikiLink Ribosome_display.
- Tralokinumab wikiPageWikiLink Ulcerative_colitis.
- Tralokinumab wikiPageWikiLinkText "Tralokinumab".
- Tralokinumab wikiPageWikiLinkText "tralokinumab".
- Tralokinumab atcPrefix "none".
- Tralokinumab c "6374".
- Tralokinumab casNumber "1044515".
- Tralokinumab chemspiderid "NA".
- Tralokinumab h "9822".
- Tralokinumab hasPhotoCollection Tralokinumab.
- Tralokinumab mabType "mab".
- Tralokinumab molecularWeight "143.87".
- Tralokinumab n "1698".
- Tralokinumab o "2014".
- Tralokinumab s "44".
- Tralokinumab source "u".
- Tralokinumab target Interleukin_13.
- Tralokinumab type "mab".
- Tralokinumab verifiedfields "changed".
- Tralokinumab verifiedrevid "470612083".
- Tralokinumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Tralokinumab wikiPageUsesTemplate Template:Drugbox.
- Tralokinumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Tralokinumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Tralokinumab wikiPageUsesTemplate Template:Reflist.
- Tralokinumab subject Category:Monoclonal_antibodies.
- Tralokinumab hypernym Antibody.
- Tralokinumab type Article.
- Tralokinumab type ChemicalSubstance.
- Tralokinumab type Drug.
- Tralokinumab type Antibody.
- Tralokinumab type Article.
- Tralokinumab type Chemical.
- Tralokinumab type Drug.
- Tralokinumab type ChemicalObject.
- Tralokinumab type Thing.
- Tralokinumab type Q8386.
- Tralokinumab comment "Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354 and taken through pre-clinical development. As of April 2012 it is being developed by MedImmune, a member of the AstraZeneca group, where it is currently in Ph3 testing for asthma and Ph2 testing for atopic dermatitis.".
- Tralokinumab label "Tralokinumab".
- Tralokinumab sameAs m.0h53vbn.
- Tralokinumab sameAs Q7833105.
- Tralokinumab sameAs Q7833105.
- Tralokinumab wasDerivedFrom Tralokinumab?oldid=673257712.
- Tralokinumab isPrimaryTopicOf Tralokinumab.